Keyphrases
Adaptive Immunity
16%
Alpha-synuclein (α-syn)
16%
Antiparkinsonian Drugs
16%
CD4+ T
100%
CD4+ T Lymphocytes
16%
Cell Subsets
16%
Cellular Expression
16%
Dopamine
16%
Dopaminergic Neurons
16%
Dopaminergic Receptors
100%
Immune System
16%
In Vitro Effect
16%
Intraneuronal
16%
Lewy Bodies
16%
Memory Cell
33%
Memory Lymphocyte
100%
Memory T Cells
16%
Microglial Activation
16%
Motor Dysfunction
16%
Motor Impairment
100%
Naïve Cells
33%
Nervous System
16%
Neuroinflammation
16%
Novel Immunotherapy
16%
Parkinson Patients
33%
Parkinson's Disease
66%
Parkinson's Disease Treatment
16%
Patients with Parkinson's Disease
100%
Receptor Expression
50%
Specific Pattern
16%
Substantia Nigra Pars Compacta
16%
Substitution Therapy
16%
T Cells
16%
Transmitter
16%
Unified Parkinson's Disease Rating Scale (UPDRS)
16%
Neuroscience
Adaptive Immunity
14%
Antiparkinson
14%
CD4
100%
Dopamine Receptor
100%
Dopaminergic
28%
Dopaminergic Neuron
14%
Immunotherapy
14%
In Vitro
28%
Lewy Body
14%
Lymphocyte
100%
Parkinson's Disease
100%
Receptor Expression
42%
Somatostatin Cell
14%
Stereotypic Movement Disorder
100%
Substantia Nigra Pars Compacta
14%
Synuclein
14%
T Cell
28%
Treatment of Parkinson's Disease
14%
Medicine and Dentistry
Adaptive Immunity
14%
Antiparkinson Agent
14%
CD4+ T Lymphocyte
14%
Dopamine Receptor
100%
Dopaminergic Neuron
14%
Immune System
14%
Immunotherapy
14%
In Vitro
28%
Lewy Body
14%
Lymphocyte
100%
Memory Cell
14%
Memory T Cell
28%
Neuroinflammation
14%
Neurological System
14%
Parkinson's Disease
100%
Receptor Expression
42%
Stereotypic Movement Disorder
100%
Substantia Nigra Pars Compacta
14%
Substitution Therapy
14%
Synuclein
14%
T Lymphocyte
14%
Treatment of Parkinson's Disease
14%
Unified Parkinson's Disease Rating Scale
14%